AEON Biopharma, Inc. (AEON)

AEON Biopharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	10.45	0.01	5.16	9.75	5.13	20.17
Cash & Short-Term Investments	10.45	0.01	5.16	9.75	5.13	20.17
Cash Growth	570.48%	-99.75%	-47.08%	90.05%	-74.57%	-81.95%
Prepaid Expenses	1.88	1.58	1.06	0.09	0.03	0.21
Total Current Assets	12.32	1.59	6.22	9.84	5.15	20.38
Property, Plant & Equipment	1.45	1.52	0.59	0.91	0.92	-
Long-Term Deferred Charges	-	-	-	-	-	0.84
Other Long-Term Assets	0.03	0.03	0.03	0.03	0.36	-
Total Assets	13.8	3.14	6.85	10.78	6.44	21.21
Accounts Payable	2.44	5.91	3.39	7.81	1.19	2.03
Accrued Expenses	6.01	8.12	9.38	3.65	4.01	2.17
Current Portion of Long-Term Debt	-	-	-	70.87	15.6	-
Current Portion of Leases	0.2	0.12	0.28	0.26	-	-
Total Current Liabilities	8.64	14.15	13.05	82.57	20.8	4.2
Long-Term Debt	13.32	11.69	-	60.43	70.76	72.16
Long-Term Leases	1.08	1.15	-	0.24	0.52	-
Other Long-Term Liabilities	2.08	4.73	146.84	-	0.22	10.14
Total Liabilities	25.12	31.71	159.89	143.24	92.31	86.5
Common Stock	0.01	0	0	0.01	0.01	0.01
Additional Paid-In Capital	411.17	403.02	381.26	187.35	187.35	158.39
Retained Earnings	-422.5	-431.6	-473.6	-474.84	-422.28	-366.65
Treasury Stock	-	-	-	-0.02	-0.02	-0.02
Comprehensive Income & Other	-	-	-60.71	-	-	-
Total Common Equity	-11.32	-28.57	-153.04	-287.5	-234.94	-208.27
Minority Interest	-	-	-	17.09	11.12	5.04
Shareholders' Equity	-11.32	-28.57	-153.04	-132.46	-85.88	-65.29
Total Liabilities & Equity	13.8	3.14	6.85	10.78	6.44	21.21
Total Debt	14.6	12.96	0.28	131.79	86.89	72.16
Net Cash (Debt)	-4.15	-12.94	4.88	-122.05	-81.76	-51.99
Net Cash Per Share	-1.80	-22.47	0.06	-63.29	-46.63	-567.46
Filing Date Shares Outstanding	11.31	10.53	0.55	1.93	1.93	0.11
Total Common Shares Outstanding	10.54	0.56	0.52	1.93	1.93	0.09
Working Capital	3.68	-12.56	-6.83	-72.74	-15.65	16.18
Book Value Per Share	-1.07	-51.43	-296.54	-149.11	-121.85	-2273.18
Tangible Book Value	-11.32	-28.57	-153.04	-287.5	-234.94	-208.27
Tangible Book Value Per Share	-1.07	-51.43	-296.54	-149.11	-121.85	-2273.18
Machinery	0.44	0.44	0.44	0.44	0.13	-
Leasehold Improvements	0.07	0.07	0.07	0.07	0.07	-

Updated Mar 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q